ASND β€” ASCENDIS PHARMA A S

Ownership history in WOLVERINE TRADING, LLC  Β·  3 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in ASCENDIS PHARMA A S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

WOLVERINE TRADING, LLC Γ— ASND AI Analytics

πŸ“ˆ WOLVERINE TRADING, LLC outperformed the S&P 500 by +967.1% annually on this ASND position. Average cost basis: $147.78. Maximum drawdown during holding period: –0.0%.

πŸ“ˆ Position Alpha vs SPY
+967.1%
annualised excess return

πŸ”₯ Exceptional β€” beat the S&P 500 by 967.1% per year on this position.
2 quarters analyzed

πŸ’° Entry Quality
$147.78
+16.8% vs current ($172.60)

Best entry: $13.27 (2016 Q2)  Β·  Worst: $172.60 (2025 Q2)

πŸ›‘οΈ Drawdown Resilience
–0.0%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
100%
buy-side decisions

3 adds Β· 0 trims. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    ASND price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 ADDED 13,000 +9,143 +237.0% 0.00% $2.2M $172.60
2023 Q2 ADDED 3,857 +3,841 +24006.2% 0.00% $337K $89.25
2016 Q2 INITIATED 16 β€” β€” 0.00% $217 $13.27

🏒 Other funds also holding ASND

As of 2025 Q4 β€” sorted by position size

Q Global Advisors, LLC 3Y 7Y 39.86% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 22.46% Avoro Capital Advisors LLC 3Y 7Y 10.71% Resolute Capital Asset Partners LLC 3Y 9.13% Tri Locum Partners LP 3Y 7.34% WESTFIELD CAPITAL MANAGEMENT CO LP 3Y 7Y 4.61% Catalio Capital Management, LP 4.49% Spyglass Capital Management LLC 3Y 7Y 4.43% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.11% PFM Health Sciences, LP 3Y 7Y 3.78%
← Back to WOLVERINE TRADING, LLC Holdings